Corvus Pharmaceuticals, Inc. · NASDAQ:CRVS
Adams Street Partners LLC reported a 3.90% stake in Corvus Pharmaceuticals, Inc. (Schedule 13D/A)
Event Jan 23, 2026 · Filed Feb 5, 2026
Adams Street Partners LLC reported a 3.90% stake in Corvus Pharmaceuticals, Inc., 3,275,616 shares, with active intent on Jan 23, 2026. Filed Feb 5, 2026 (Schedule 13D/A).
- Stake
- 3.90%
- Shares
- 3,275,616
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adams Street Partners, LLC | 3.90% | 3,275,616 |
| Adams Street 2011 Direct Fund LP | 0.80% | 694,854 |
| Adams Street 2012 Direct Fund LP | 0.90% | 715,361 |
| Adams Street 2013 Direct Fund LP | 0.60% | 541,133 |
| Adams Street 2014 Direct Fund LP | 0.90% | 736,033 |
| Adams Street 2015 Direct Venture/Growth Fund LP | 0.10% | 69,864 |
| Adams Street 2016 Direct Venture/Growth Fund LP | 0.10% | 67,769 |
| Adams Street 2017 Direct Venture/Growth Fund LP | 0.10% | 87,668 |
| Adams Street 2018 Direct Venture/Growth Fund LP | 0.20% | 126,806 |
| Adams Street Venture/Growth Fund VI LP | 0.30% | 236,128 |
Source
Related
- Corvus Pharmaceuticals, Inc.
- Adams Street Partners LLC
- Corvus Pharmaceuticals, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Moore David Scott · Jun 15, 2026
- Form 4 · Miller Richard A Md · May 20, 2026
- Schedule 13G · Sirenia Capital Management LP · May 15, 2026